Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၁.၇၄%
၁,၀၉၄.၈၄
+၁၈.၇၁
+၁.၇၄%
—၁,၀၇၆.၁၃၁,၀၇၉.၈၉၁,၁၀၀.၇၇၁,၀၇၉.၈၉——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၄၂%
၆၀၄.၂၁
-၂.၅၃
-၀.၄၂%
—၆၀၆.၇၄၆၀၆.၇၄၆၀၇.၉၀၆၀၂.၀၃——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၀၇%
၁,၂၄၉.၇၁
+၀.၈၉
+၀.၀၇%
—၁,၂၄၈.၈၂၁,၂၄၆.၃၇၁,၂၅၆.၄၂၁,၂၃၉.၀၈——
SIXI
Industrials
SIXI
Industrials
SIXI
+၀.၈၆%
၁,၇၃၉.၂၆
+၁၄.၉၀
+၀.၈၆%
—၁,၇၂၄.၃၆၁,၇၃၃.၀၂၁,၇၄၅.၇၅၁,၇၂၇.၇၆——
SIXM
Financials
SIXM
Financials
SIXM
+၀.၀၁%
၆၃၅.၆၃
+၀.၀၄၀
+၀.၀၁%
—၆၃၅.၅၉၆၃၅.၀၈၆၃၇.၉၆၆၃၃.၃၁——
SIXR
Staples
SIXR
Staples
SIXR
+၀.၆၁%
၈၄၈.၃၂
+၅.၁၇
+၀.၆၁%
—၈၄၃.၁၅၈၄၂.၅၀၈၅၂.၇၇၈၄၀.၈၅——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၀.၂၂%
၂၁၆.၇၆
+၀.၄၇
+၀.၂၂%
—၂၁၆.၂၉၂၁၆.၂၉၂၁၇.၃၀၂၁၅.၂၄——
SIXT
Technology
SIXT
Technology
SIXT
+၂.၂၀%
၃,၃၃၅.၁၄
+၇၁.၇၃
+၂.၂၀%
—၃,၂၆၃.၄၁၃,၂၉၆.၂၅၃,၃၄၃.၆၆၃,၂၉၅.၄၂——
SIXU
Utilities
SIXU
Utilities
SIXU
+၀.၀၁%
၉၃၉.၃၄
+၀.၁၀
+၀.၀၁%
—၉၃၉.၂၄၉၄၁.၅၇၉၄၈.၁၁၉၃၉.၁၁——
SIXV
Health care
SIXV
Health care
SIXV
+၀.၃၈%
၁,၄၆၈.၁၇
+၅.၆၁
+၀.၃၈%
—၁,၄၆၂.၅၆၁,၄၆၅.၀၃၁,၄၇၁.၅၆၁,၄၅၉.၆၆——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၈%
၂,၃၈၇.၀၉
+၆.၆၉
+၀.၂၈%
—၂,၃၈၀.၄၀၂,၃၉၄.၉၂၂,၄၁၂.၁၃၂,၃၈၆.၈၂——
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
၇၄.၉၃ US$
-၁.၉၁%
(-၁.၄၆) 1D
၇၄.၉၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: မေ ၅, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARWR...
Open
၇၇.၂၅ US$
High
၇၇.၉၀ US$
Low
၇၃.၆၂ US$
Mkt. cap
ဋေ ၁.၀၅ ထ
Avg. vol.
၁.၈၅ သန်း
Volume
၁.၂၆ သန်း
P/E ratio
၄၈.၆၃
52-wk high
၇၇.၉၀ US$
52-wk low
၁၂.၄၄ US$
EPS
၁.၅၄ US$
Beta
၁.၂၈
Shares outstanding
၁၄.၀၀ ကုဋေ
No. of employees
၇၁၁
News stories
From sources across the web
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Arrowhead Pharmaceuticals stock hits 52-week high at 77.23 USD
Business Wire
Business Wire
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
TIKR.com
TIKR.com
·
ပြီးခဲ့သည့် ၁၇ နာရီ
JPMorgan Expects Arrowhead Pharma Stock to Rally on RNAi Portfolio Growth
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Arrowhead Pharmaceuticals (ARWR) Valuation Check After Australian Approval Expands REDEMPLO Opportunity
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees၇၁၁
Founded၂၀၀၄ ဇန် ၁
HeadquartersPasadena, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitearrowheadpharma.com
Last report
၂၀၂၆ ဖေ ၅
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၀.၂၂/ (-၀.၃၇ est.)USD
+၁၅၉.၈၆%beat
Revenue / Estimate
၂၆.၄၀ ကုဋေ/ (၂၃.၀၈ ကုဋေ est.)USD
+၁၄.၃၈%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၅၄.၂၇ ကုဋေ
၂.၇၈ ကုဋေ
၂၅.၆၅ ကုဋေ
၂၆.၄၀ ကုဋေ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁၂.၅၄ ကုဋေ
၁၅.၅၉ ကုဋေ
၁၈.၁၁ ကုဋေ
၁၇.၃၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၆၁ ကုဋေ
၃.၇၄ ကုဋေ
၃.၁၃ ကုဋေ
၄.၉၇ ကုဋေ
Operating expense
၁၆.၁၅ ကုဋေ
၁၉.၃၃ ကုဋေ
၂၁.၂၄ ကုဋေ
၂၂.၃၂ ကုဋေ
Total operating expenses
၁၆.၁၅ ကုဋေ
၁၉.၃၃ ကုဋေ
၂၁.၂၄ ကုဋေ
၂၂.၃၂ ကုဋေ
Operating income
၃၈.၁၂ ကုဋေ
-၁၆.၅၆ ကုဋေ
၄.၄၁ ကုဋေ
၄.၀၈ ကုဋေ
Other non operating income
၄.၃၈ သိန်း
-၁.၇၆ သိန်း
၄.၆၆ သန်း
၂.၇၇ သိန်း
EBT including unusual items
၃၆.၉၆ ကုဋေ
-၁၇.၉၁ ကုဋေ
၃.၆၁ ကုဋေ
၂.၈၃ ကုဋေ
EBT excluding unusual items
၃၆.၉၆ ကုဋေ
-၁၇.၉၁ ကုဋေ
၃.၆၁ ကုဋေ
၂.၈၃ ကုဋေ
Income tax expense
၁.၇၅ သန်း
-၄.၃၇ သိန်း
၂.၀၀ ကုဋေ
၂.၉၀ သောင်း
Effective tax rate
၀.၄၇%
၀.၂၄%
၅၅.၃၇%
၀.၁၀%
Other operating expenses
-
-
-
-
Net income
၃၇.၀၄ ကုဋေ
-၁၇.၅၂ ကုဋေ
-၂.၃၈ ကုဋေ
၃.၀၈ ကုဋေ
Net profit margin
၆၈.၂၆%
-၆၃၁.၁၁%
-၉.၂၆%
၁၁.၆၇%
Earnings per share
၂.၇၅
-၁.၂၆
-၀.၁၈
၀.၂၂
Interest and investment income
၉.၆၂ သန်း
၁.၁၀ ကုဋေ
၉.၀၅ သန်း
၉.၆၉ သန်း
Interest expense
-၂.၁၆ ကုဋေ
-၂.၄၄ ကုဋေ
-၂.၁၇ ကုဋေ
-၂.၂၅ ကုဋေ
Net interest expenses
-၁.၂၀ ကုဋေ
-၁.၃၄ ကုဋေ
-၁.၂၆ ကုဋေ
-၁.၂၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၈.၇၃ ကုဋေ
-၁၅.၉၃ ကုဋေ
၅.၀၅ ကုဋေ
၄.၇၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer